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We examined the association of diet with insulin-like growth factors (IGF) in 344 disease-free men. Raised levels of IGF-I and/or its
molar ratio with IGFBP-3 were associated with higher intakes of milk, dairy products, calcium, carbohydrate and polyunsaturated fat;
lower levels with high vegetable consumption, particularly tomatoes. These patterns support the possibility that IGFs may mediate
some diet–cancer associations.
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High circulating levels of insulin-like growth factor-I (IGF-I) are
associated with an increased risk of developing prostate (Chan
et al, 1998; Harman et al, 2000; Stattin et al, 2000; Chokkalingam
et al, 2001) and other cancers (Holly et al, 1999). In serum and
body fluids, IGF-I’s activity is regulated by a complex system of six
binding proteins and an acid-labile subunit. Most (90%) circulat-
ing IGF-I is bound to IGF binding protein-3 (IGFBP-3) and
associations of IGFs with prostate cancer are generally strongest
with the molar ratio (IGF-I/IGFBP-3) or in statistical models
controlling for IGFBP-3 (Chan et al, 1998; Harman et al, 2000;
Stattin et al, 2000; Chokkalingam et al, 2001). Raised levels of
bioavailable IGF-I may, therefore, increase cancer risk, and raised
IGFBP-3, by reducing IGF-I’s bioavailability, may reduce risk.
IGF-I plays a role in energy and protein metabolism as well as
modulating cell turnover and apoptosis (Thissen et al, 1994; Holly
et al, 1999). Energy restriction leads to reduced production of IGF-
I (Thissen et al, 1994), and animal experiments suggest that this
pathway mediates the cancer-protective role of diet restriction
(Dunn et al, 1997). Other dietary influences on IGFs may underlie
some of the diet–prostate cancer associations observed. While no
specific food or nutrient is an established risk factor for prostate
cancer, dietary aspects most consistently related to its risk are red
meat, animal fat, calcium and dairy product consumption and
lower consumption of vegetables (Kolonel, 1996; World Cancer
Research Fund, 1997; Department of Health, 1998). Diets rich in
tomatoes, a major source of the carotenoid lycopene, are
associated with reduced risk (Giovannucci, 1999).
Several, generally small, cross-sectional studies have examined
the association of diet with the IGF axis (Darling-Raedeke et al,
1998; Kaklamani et al, 1999; Allen et al, 2000; Signorello et al, 2000;
Mucci et al, 2001; Holmes et al, 2002; Giovannucci et al, 2003). The
largest investigation (n¼1037) (Holmes et al, 2002) reported that
higher levels of energy, protein and milk intake were associated
with raised IGF-I and high fat intake with low IGFBP-3, broadly
consistent with previous, smaller, studies (Kaklamani et al, 1999;
Ma et al, 2001). Other studies have reported reduced levels of IGF-I
with tomato consumption (Mucci et al, 2001) and vegan diets
(Allen et al, 2000). There has been only one (Giovannucci et al,
2003) large-scale investigation of the association of diet with IGF in
community-based men.
MATERIALS AND METHODS
Within a case–control study nested in a population-based
investigation into the early detection and management of prostate
cancer (ProtecT; Donovan et al, 2002), stored blood samples from
368 disease-free men (controls) were assayed for IGF-I and IGFBP-
3. Controls were matched to cases on age, general practice and date
of recruitment. Included in this analysis are the 344 (95%) of these
disease-free men who completed a 114-item validated food-
frequency questionnaire (FFQ) (Bingham et al, 1997). Over two-
thirds (n¼242) of the men also provided information on
occupation, smoking and physical activity and had height and
weight measured. Ethical approval was obtained from the relevant
multicentre and local research ethics committees.
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Royal Society of Chemistry and MAFF, 1991) and portion size data
for men of this age (Ministry of Agriculture and Food, 1993), we
estimated weekly consumption of: energy, carbohydrate, protein,
total fat, saturated and polyunsaturated fat, calcium, red meat,
dairy products, vegetables, milk, tomatoes and foods containing
tomatoes (baked beans, tomato ketchup and tomato juice). These
were selected on the basis of research findings and reviews
examining associations of diet with prostate cancer (World Cancer
Research Fund, 1997; Giovannucci, 1999; Chan and Giovannucci,
2001) and the IGF-axis (Ma et al, 2001; Holmes et al, 2002). Given
difficulties in measuring lycopene from FFQs (Kristal and Cohen,
2000), we used the frequency of reported consumption of tomatoes
and products with high tomato content.
Laboratory methods
Non-fasted blood specimens, taken using standard techniques,
were spun and frozen to  801C within 18h. For the IGF-I assays,
an ELISA kit was used (Diagnostic Systems Laboratories, TX,
USA). Assays for serum IGFBP-3 used a previously validated ‘in-
house’ double antibody radioimmunoassay (Cheetham et al, 1998).
The average coefficients of variation for intra-assay variability for
IGF-I and IGFBP-3 were 3 and 3.6%, and for inter-assay variation
were 15 and 14%. To measure (crudely) bioavailable IGF-I, we
multiplied the molar ratio of IGF-I/IGFBP-3 by 5.33 (molecular
weights 40000 and 7500Da, respectively).
Statistical analysis
Using Stata (Stata Corporation, 2001) we calculated age-, centre-
and energy-adjusted levels of IGF-I, IGFBP-3 and the molar ratio in
quartiles of the distribution of each dietary factor. Intakes of
individual food groups were considered in three a priori
categories. Adjustment for overall energy intake means that
dietary measures relate to dietary composition rather than
absolute intake (Willett, 1998).
Least-squares linear regression models investigated change in
growth factor levels for a one standard deviation increase in each
dietary factor. Log or square-root transformations were used
for the latter due to positive skewness, and sampling weights
adjusted for the dependence on the age distribution of cases. Tests
for trend were based on the continuous variable (for nutrients and
food groups) or three-level category (for tomato products and
milk).
We assessed possible confounding by exercise, smoking, body
mass index (BMI) and socioeconomic position in the 242 men with
complete data.
Table 1 Age-, centre- and energy-adjusted levels of IGF-I, IGFBP-3 and IGF-I/IGFBP-3molar ratio in relation to quartiles of increasing intake of dietary
variables (n¼344)
a
Quartile
1 (low intake) 2 3 4 (high intake)
Change in growth factor
(95% CI) per s.d. increase
in each dietary variable
P-value
(linear trend)
b
IGF-I (ngml
 1)
Energy intake (MJ) 119.9 133.8 129.3 125.8 1.2 ( 3.6 to 5.9) 0.63
Carbohydrates (g) 109.2 128.6 129.6 141.5 10.0 ( 1.2 to 21.2) 0.08
Protein (g) 115.7 137.4 131.5 124.9 2.6 ( 6.5 to 11.8) 0.57
Fat (g) 121.1 125.4 125.3 137.2 5.0 ( 4.6 to 14.6) 0.30
Polyunsaturated fat (g) 114.4 122.6 136.2 136.1 9.1 (1.6 to 16.5) 0.017
Saturated fat (g) 125.3 121.4 128.5 133.9 1.8 ( 6.5 to 10.2) 0.67
Red meat (g) 125.2 134.2 135.3 117.8  2.7 ( 8.3 to 2.9) 0.35
Dairy products (g) 117.8 130.7 125.6 134.1 4.4 ( 0.8 to 9.7) 0.09
Calcium (mg) 120.5 119.1 137.2 131.8 6.5 (0.5 to 12.5) 0.035
Vegetables (g) 134.1 125.9 122.8 126.5  2.1 ( 8.3 to 4.1) 0.50
IGFBP-3 (ngml
 1)
Energy intake (MJ) 3281.6 3479.5 3494.2 3328.1 15.4 ( 101.6 to 132.4) 0.80
Carbohydrates (g) 3017.2 3423.7 3541.0 3598.2 184.5 ( 131.6 to 500.7) 0.25
Protein (g) 3120.7 3408.3 3651.0 3395.1 150.0 ( 107.2 to 407.2) 0.25
Fat (g) 3564.5 3387.7 3299.6 3335.9  85.8 ( 329.8 to 158.3) 0.49
Polyunsaturated fat (g) 3272.0 3288.7 3357.0 3667.2 228.1 ( 1.2 to 457.4) 0.05
Saturated fat (g) 3465.4 3514.0 3444.0 3162.4  170.4 ( 374.7 to 33.9) 0.10
Red meat (g) 3469.4 3389.2 3521.4 3196.7  78.0 ( 196.5 to 40.4) 0.20
Dairy products (g) 3348.8 3450.2 3385.1 3396.2 3.9 ( 139.4 to 147.3) 0.96
Calcium (mg) 3345.5 3326.7 3540.2 3368.1 81.2 ( 95.6 to 258.1) 0.37
Vegetables (g) 3164.8 3637.4 3401.5 3374.8 93.8 ( 55.7 to 243.4) 0.22
IGF-I:IGFBP-3molar ratio
Energy intake (MJ) 0.206 0.221 0.210 0.213  0.001 ( 0.012 to 0.010) 0.85
Carbohydrates (g) 0.202 0.214 0.209 0.226  0.009 ( 0.034 to 0.016) 0.48
Protein (g) 0.204 0.231 0.204 0.213  0.002 ( 0.021 to 0.018) 0.88
Fat (g) 0.193 0.208 0.214 0.235 0.011 ( 0.007 to 0.029) 0.23
Polyunsaturated fat (g) 0.200 0.212 0.231 0.208  0.002 ( 0.017 to 0.013) 0.84
Saturated fat (g) 0.208 0.196 0.210 0.238 0.012 ( 0.006 to 0.030) 0.19
Red meat (g) 0.204 0.224 0.221 0.209 0.001 ( 0.008 to 0.011) 0.82
Dairy products (g) 0.205 0.209 0.212 0.225 0.007 ( 0.003 to 0.018) 0.18
Calcium (mg) 0.207 0.204 0.218 0.222 0.006 ( 0.008 to 0.019) 0.39
Vegetables (g) 0.236 0.206 0.201 0.209  0.011 ( 0.022 to  0.000) 0.045
aAll values are controlled for age, study centre and energy intake, except that for energy intake, which is controlled for age and study centre only. All models are weighted by the
inverse of the sampling probability in relation to age.
bTests for trend based on continuous measure of diet.
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Mean age was 62.2 years (range 50–70) and most men (90%) were
nonsmokers and came from nonmanual social classes (64%). Mean
(s.d.) blood levels of IGF-I, IGFBP-3 and the molar ratio (IGF-I/
IGFBP-3) were 126.6ngml
 1 (36.9), 3393.6ngml
 1 (1049.8) and
0.21 (0.08), respectively. Median daily intakes were as follows:
energy: 10.3MJ; carbohydrate: 314.8g; protein: 89.5g; fat: 77.6g;
red meat: 46.9g; dairy products 344.9g; calcium 1126.3g;
vegetables 271.0g.
Raised IGF-I levels were seen in men consuming higher levels of
polyunsaturated fat (Ptrend¼0.017) and calcium (Ptrend¼0.035)
(Table 1). There were weaker positive associations with carbohy-
drate and dairy products. IGFBP-3 levels were weakly positively
associated with polyunsaturated fats (Ptrend¼0.05) and inversely
associated with saturated fats (Ptrend¼0.10). The molar ratio was
inversely related to vegetable intake (Ptrend¼0.045).
Controlling for BMI, social class, smoking and exercise
attenuated the associations of IGF-I and IGFBP-3 with carbohy-
drates, polyunsaturated fats and, to a lesser extent, vegetables (not
shown). Associations of dairy products and calcium with IGF-I and
saturated fat with IGFBP-3 were not confounded.
IGF-I tended to be lower and IGFBP-3 higher in those who ate
tomatoes or tomato-containing products more frequently,
although evidence for a trend was only clear for IGF-I/IGFBP-
3molar ratio (Table 2). Men consuming higher levels of milk had
raised levels of IGF-I (Ptrend¼0.004). There was no association
between milk intake and IGFBP-3 and the molar ratio was highest
in those men drinking at least one pint of milk per day. These
associations were little changed after adjustment for BMI, social
class, smoking and exercise (not shown). Associations of IGF-I
with milk were not confounded by calcium intake, whereas
associations with calcium intake were attenuated in models
controlling for milk intake.
Excluding men (n¼95) reporting low levels of energy intake in
relation to their estimated basal metabolic rate (ratio of energy
intake/basal metabolic rate o1.2 (Joint FAO/WHO/UN Expert
Consultation, 1985)) did not change the associations with milk
intake, tomato-rich products or vegetable intake.
DISCUSSION
In a group of healthy, community-sampled, middle-aged men, we
found associations of the IGF-axis with several aspects of diet
linked previously to prostate cancer. Positive relations were seen
with dairy products, milk and calcium intake, all of which were
associated with raised IGF-I levels. High intakes of vegetables and
Table 2 Age-, centre- and energy-adjusted mean levels of IGF-I, IGFBP-3 and IGF-I/IGFBP-3 molar ratio in relation to increasing levels of intake of
tomatoes, tomato-rich products and milk
a
Weekly consumption
IGF-I (ngml
 1) (no. with data) oOnce per week 1–4 times per week 5+ times per week P-trend
Tomatoes (n¼342) 139.2 (n¼45) 125.3 (n¼232) 126.3 (n¼65) 0.19
Baked beans (n¼341) 129.3 (n¼139) 126.8 (n¼196) 119.6 (n¼6) 0.55
Tomato ketchup (n¼343) 130.3 (n¼233) 121.6 (n¼100) 120.4 (n¼10) 0.10
Tomato juice (n¼343) 127.9 (n¼324) 122.9 (n¼14) 87.0 (n¼5) 0.14
Daily consumption
o 1
2 pint 1
2   3
4 pint 1+ pints
Milk (n¼342) 117.8 (n¼95) 126.2 (n¼173) 140.7 (n¼74) 0.004
Weekly consumption
IGFBP-3 (ngml
 1) oOnce per week 1–4 times per week 5+ times per week P-trend
Tomatoes (n¼342) 3648.8 3322.2 3504.9 0.70
Baked beans (n¼341) 3377.9 3424.4 3743.0 0.63
Tomato ketchup (n¼343) 3275.7 3732.1 2968.9 0.09
Tomato juice (n¼343) 3383.1 3958.7 2715.9 0.47
Daily consumption
o 1
2 pint 1
2   3
4 pint 1+ pints
Milk (n¼342) 3343.9 3394.6 3465.7 0.62
Weekly consumption
IGF-I/BP-3 molar ratio oOnce per week 1–4 times per week 5+ times per week P-trend
Tomatoes (n¼342) 0.221 0.214 0.204 0.28
Baked beans (n¼341) 0.214 0.212 0.177 0.64
Tomato ketchup (n¼343) 0.224 0.187 0.223 0.005
Tomato juice (n¼343) 0.214 0.178 0.177 0.004
Daily consumption
o 1
2 pint 1
2   3
4 pint 1+ pints
Milk (n¼342) 0.206 0.209 0.230 0.17
aAll values are controlled for age, study centre and energy intake and are weighted by the inverse of the sampling probability in relation to age.
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lower levels of IGF-I or its molar ratio. In contrast to some other
studies (Kaklamani et al, 1999; Holmes et al, 2002), we found only
weak associations with saturated fat and no evidence of an
association with red meat.
Associations were not confounded by socioeconomic position or
lifestyle. While we have examined associations with a range of
dietary variables and three different measures of the IGF-axis,
thereby increasing the possibility of chance results, our findings
are consistent with previous studies. In a cross-sectional study, it is
not possible to determine whether dietary associations arise as the
result of long-term intake of particular foods/nutrients or reflect
patterns of intake around the time of blood sampling.
Association of IGF-I levels with dairy products, milk and
calcium are consistent with some (Heaney et al, 1999; Ma et al,
2001; Holmes et al, 2002) but not all (Mucci et al, 2001) previous
analyses. The strongest evidence of a causal association between
higher levels of milk consumption and IGF comes from a
randomised trial of dietary milk supplementation, reporting a rise
in IGF-I in those supplemented but not the controls (Heaney et al,
1999). While some research suggests that neonates absorb IGF-I
from breast milk (Diaz-Gomez et al, 1997), there is no strong
evidence that bovine IGF-I in cows milk could be similarly
absorbed from the gut (Holmes et al, 2002). Dietary intake of
animal protein (essential amino acids) is known to stimulate IGF-I
production (Thissen et al, 1994), but we found no evidence of
associations with animal protein intake, nor that controlling for
animal protein intake attenuated associations with milk (not
shown). This contrasts with the findings of Giovannucci et al
(2003) and Holmes et al (2002). In Giovannucci et al’s analysis,
associations with vegetable protein were, however, of similar
magnitude to those for animal protein.
Associations of calcium, milk and dairy products with IGF-I
suggest a possible pathway linking dietary intake of these factors
with prostate cancer (Chan and Giovannucci, 2001). The relation of
these dietary aspects with prostate cancer risk are, however, in the
opposite direction to their association with colorectal cancer (Ma
et al, 2001; Wu et al, 2002), another neoplasm associated with
raised IGF-I levels (Ma et al, 1999). The IGF–cancer associations
seen for a range of different cancer sites (Holly et al, 1999; Yu and
Rohan, 2000) may not therefore be explained in terms of common
dietary influences on the growth factor axis. Nevertheless, our
finding that vegetable intake was weakly related to lower molar
ratios is consistent with the observation that vegetable-rich diets
appear to protect against colorectal, breast and prostate cancer
(World Cancer Research Fund, 1997), although associations of
vegetable intake with IGF-I or IGFBP-3 have not been found in
other studies (Kaklamani et al, 1999; Holmes et al, 2002).
The weak associations of IGFs with tomatoes and tomato-
containing products support those reported for 112 Greek men
(Mucci et al, 2001), where a strong inverse association was found
between cooked tomato consumption and IGF-I. Likewise, in the
Nurses Study intake of lycopene was positively associated with
circulating levels of IGFBP-3 (but not IGF-I). These findings hint at
the possible importance of the IGF axis in mediating the protective
effect of higher levels of tomato or lycopene intake on prostate
cancer reported in several investigations (Giovannucci, 1999). A
possible biological mechanism lies in the reported inhibitory
effects of lycopene on IGF-I receptor signalling and cell cycle
progression (Karas et al, 2000), but a small trial of lycopene
supplementation found no difference in IGF-I levels in supple-
mented vs control subjects (Kucuk et al, 2001).
International comparisons of cancer incidence and changes in
incidence in migrants moving between different continents,
indicates large dietary influences on epithelial cancer incidence
(World Cancer Research Fund, 1997). Our study adds to evidence
that aspects of diet previously linked to prostate cancer may
influence cancer risk through the IGF-axis. Trials of dietary
interventions aimed at reducing bioavailable IGF-I are now
required. Identification of relevant aspects of diet could then lead
to trials of dietary interventions against cancer incorporating
measurements of IGF-I.
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